Delivering Advanced Healthcare Solutions Through Research And Innovation To Improve The Quality Of Human Life

In The News

Thin-Strut Bioresorbable Vascular Scaffold Shows Promise

December 27, 2019

The MeRes 100 thin-strut sirolimus-eluting bioresorbable scaffold, developed by Meril Life Sciences, demonstrated zero scaffold thrombosis and very low major adverse cardiac event rates for up to three years, according to two recent clinical trials.

In The News

At The Heart Of Life, At The Heart Of Precision - Get Pumped Up About Heart Health

December 26, 2019

Meril has become the first Indian company in the world to make the Transcatheter Aortic Valve Replacement (TAVR) therapy available for patients. The human heart has four valves that are synchronized to open and close according to the heart’s rhythm.

In The News

Initial experience with the new ethylene vinyl alcohol copolymer based liquid embolic agent Menox in the endovascular treatment of cerebral arteriovenous malformations

December 25, 2019

Background and Purpose Liquid embolic agents (LEAs) are the determinant tool for successful embolization of cranial arteriovenous shunts. There are few currently available LEAs.


Founded in 2006, Meril is an India-based global medical device company that is dedicated to the innovation, design and development of novel, clinically relevant and state-of-the-art devices